Skip to main content

Traditional Chinese Medicine Use among Chinese Immigrant Cancer Patients

Journal of Cancer Education volume 29, pages 56–61 (2014)Cite this article

Abstract

Traditional Chinese Medicine (TCM) includes both herbal remedies and non-herbal practices. Chinese cancer patients are particularly at high risk for herb–drug interactions. Providers, both primary care physicians and oncologists, frequently do not ask patients about TCM use, which has potentially dangerous consequences. This study describes an assessment of TCM use while undergoing conventional cancer treatment, among a cohort of Chinese immigrant cancer patients in New York City. The Immigrant Health and Cancer Disparities Service at Memorial Sloan–Kettering Cancer Center assists underserved cancer patients through a patient navigation program, the Cancer Portal Project. Six questions related to TCM are included in the existing Portal Needs Assessment Intake. Mandarin- or Cantonese-speaking Portal patients enrolled between January 2010 and May 2012 were surveyed. One hundred nine Chinese-speaking patients were enrolled in the Portal Project during the study period. Forty-six completed the TCM questions. Ninety-six percent preferred to speak Mandarin, Cantonese, or Fujianese in the healthcare setting. Thirty-nine percent (n = 18) of the 46 participants reported using TCM since being diagnosed with cancer. Nearly all (n = 16) who used TCM reported using herbal medicines. Ten TCM users did not describe sharing their use with Western doctors. Eight (44 %) of TCM users reported concurrently using TCM and conventional cancer treatment. Larger scale studies should further explore the concurrent use of TCM and conventional cancer treatment in this unique population. Future research should also address patient–provider communication related to the concurrent use of TCM and cancer treatment. This is also an important area of education for both patients and providers.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Su D, Li L (2011) Trends in the use of complementary and alternative medicine in the United States: 2002–2007. J Health Care Poor Underserved 22(1):296–310. doi:10.1353/hpu.2011.0002

    PubMed  Google Scholar 

  2. Ferro MA, Leis A, Doll R, Chiu L, Chung M, Barroetavena MC (2007) The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients. Support Care Cancer 15(8):985–992. doi:10.1007/s00520-007-0285-0

    Article  PubMed  Google Scholar 

  3. Chiu J, Yau T, Epstein RJ (2009) Complications of traditional Chinese/herbal medicines (TCM)—a guide for perplexed oncologists and other cancer caregivers. Support Care Cancer 17(3):231–240. doi:10.1007/s00520-008-0526-x

    Article  PubMed  Google Scholar 

  4. Abdullah AS, Lau Y, Chow LW (2003) Pattern of alternative medicine usage among the Chinese breast cancer patients: implication for service integration. Am J Chin Med 31(4):649–658

    Article  PubMed  Google Scholar 

  5. Liu JM, Chu HC, Chin YH, Chen YM, Hsieh RK, Chiou TJ, Whang-Peng J (1997) Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 27(1):37–41

    CAS  Article  PubMed  Google Scholar 

  6. Deng G, Cassileth BR, Yeung KS (2004) Complementary therapies for cancer-related symptoms. J Support Oncol 2:419–426

    PubMed  Google Scholar 

  7. Gerber B, Scholz C, Reimer T, Briese V, Janni W (2006) Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 95(3):199–209. doi:10.1007/s10549-005-9005-y

    CAS  Article  PubMed  Google Scholar 

  8. Maskarinec G, Shumay DM, Kakai H, Gotay CC (2000) Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 6(6):531–538

    CAS  Article  PubMed  Google Scholar 

  9. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92(1):42–47

    CAS  Article  PubMed  Google Scholar 

  10. Dhingra L, Lam K, Homel P, Chen J, Chang VT, Zhou J, Chan S, Lam WL, Portenoy R (2011) Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates. Oncologist 16(4):523–533. doi:10.1634/theoncologist.2010-0330

    PubMed Central  Article  PubMed  Google Scholar 

  11. Saw JT, Bahari MB, Ang HH, Lim YH (2006) Potential drug–herb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 12(4):236–241. doi:10.1016/j.ctcp.2006.06.002

    Article  PubMed  Google Scholar 

  12. Yang AK, He SM, Liu L, Liu JP, Wei MQ, Zhou SF (2010) Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem 17(16):1635–1678

    CAS  Article  PubMed  Google Scholar 

  13. American Cancer Society. Guide to Cancer Drugs. 2012. http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/docetaxel?url=http%3A www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/docetaxel. Accessed May 2013

  14. Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A (2002) Effects of St John's wort on irinotecan metabolism. J Natl Cancer Inst 94(16):1247–1249

    CAS  Article  PubMed  Google Scholar 

  15. Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ (2004) Effect of St John's wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther 76(4):323–329. doi:10.1016/j.clpt.2004.06.007

    CAS  Article  PubMed  Google Scholar 

  16. Cox MC, Low J, Lee J, Walshe J, Denduluri N, Berman A, Permenter MG et al (2006) Influence of Garlic (Allium sativum) on the pharmacokinetics of docetaxel. Clin Cancer Res 12(15):4636–4640. doi:10.1158/1078-0432.ccr-06-0388

    CAS  Article  PubMed  Google Scholar 

  17. Meijerman I, Beijnen JH, Schellens JH (2006) Herb–drug interactions in oncology: focus on mechanisms of induction. Oncologist 11(7):742–752. doi:10.1634/theoncologist.11-7-742

    CAS  Article  PubMed  Google Scholar 

  18. Yap KY, See CS, Chan A (2010) Clinically relevant chemotherapy interactions with complementary and alternative medicines in patients with cancer. Recent Pat Food Nutr Agric 2(1):12–55

    CAS  Article  PubMed  Google Scholar 

  19. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57(4):190–205

    Article  PubMed  Google Scholar 

  20. Wu AP, Burke A, LeBaron S (2007) Use of traditional medicine by immigrant Chinese patients. Fam Med 39(3):195–200

    PubMed  Google Scholar 

  21. Klabunde CN, Ambs A, Keating NL, He Y, Doucette WR, Tisnado D, Clauser S, Kahn KL (2009) The role of primary care physicians in cancer care. J Gen Intern Med 24(9):1029–1036. doi:10.1007/s11606-009-1058-x

    PubMed Central  Article  PubMed  Google Scholar 

  22. Gany F, Ramirez J, Nierodzick ML, McNish T, Lobach I, Leng J (2011) Cancer portal project: a multidisciplinary approach to cancer care among Hispanic patients. J Oncol Pract 7(1):31–38. doi:10.1200/JOP.2010.000036

    PubMed Central  Article  PubMed  Google Scholar 

  23. Leng J, Lee T, Sarpel U, Lau J, Li Y, Cheng C, Chang MD, Gany F (2012) Identifying the informational and psychosocial needs of Chinese immigrant cancer patients: a focus group study. Support Care Cancer 20(12):3221–3229. doi:10.1007/s00520-012-1464-1

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge Michell Chang-Qui, Maria Xia, and Mei Hsuan Chen for their assistance with data collection and data entry for this study. This study was conducted with funding from NCI grant #U54-13778804-S2.

Conflict of Interest

None of the authors have any conflicts of interest

Author information

Affiliations

  1. Memorial Sloan–Kettering Cancer Center, Immigrant Health and Cancer Disparities Service, Department of Psychiatry and Behavioral Sciences, Department of Medicine; Weill Cornell Medical College, Department of Public Health, 300 E. 66th St., 15th Floor, New York, NY, 10065, USA

    Jennifer C. F. Leng & Francesca Gany

Authors
  1. Jennifer C. F. Leng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Gany
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer C. F. Leng.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Leng, J.C.F., Gany, F. Traditional Chinese Medicine Use among Chinese Immigrant Cancer Patients. J Canc Educ 29, 56–61 (2014). https://doi.org/10.1007/s13187-013-0542-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-013-0542-5

Keywords

  • Traditional Chinese Medicine
  • Cancer Treatment
  • Patient–Provider Communication
  • Herb–Drug Interactions
  • Alternative Medicine